{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:20:05Z","timestamp":1791508805149,"version":"4.3.4"},"reference-count":80,"publisher":"Informa UK Limited","issue":"26","funder":[{"DOI":"10.13039\/100005191","name":"Craig H. Neilsen Foundation","doi-asserted-by":"crossref","award":["#441259"],"award-info":[{"award-number":["#441259"]}],"id":[{"id":"10.13039\/100005191","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Connaught New Investigator Award"},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Disability and Rehabilitation"],"published-print":{"date-parts":[[2020,12,17]]},"DOI":"10.1080\/09638288.2019.1610085","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T07:59:12Z","timestamp":1557388752000},"page":"3858-3870","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Spinal cord injury and polypharmacy: a scoping review"],"prefix":"10.1080","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-8163","authenticated-orcid":false,"given":"Lauren","family":"Cadel","sequence":"first","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-6925","authenticated-orcid":false,"given":"Amanda","family":"C. Everall","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-9250","authenticated-orcid":false,"given":"Sander L.","family":"Hitzig","sequence":"additional","affiliation":[{"name":"St. John\u2019s Rehab Research Program, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada;"},{"name":"Department of Occupational Science and Occupational Therapy, Faculty of Medicine, University of Toronto, Toronto, Canada;"},{"name":"Rehabilitation Science Institute, Faculty of Medicine, University of Toronto, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4831-7691","authenticated-orcid":false,"given":"Tanya L.","family":"Packer","sequence":"additional","affiliation":[{"name":"School of Occupational Therapy and Health Administration, Dalhousie University, Halifax, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3002-8306","authenticated-orcid":false,"given":"Tejal","family":"Patel","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Waterloo, Kitchener, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-0894","authenticated-orcid":false,"given":"Aisha","family":"Lofters","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Canada;"},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-9139","authenticated-orcid":false,"given":"Sara J. T.","family":"Guilcher","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada;"},{"name":"Rehabilitation Science Institute, Faculty of Medicine, University of Toronto, Toronto, Canada;"},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada;"},{"name":"St. Michael\u2019s Hospital, Centre for Urban Health Solutions, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sc.2012.158","article-title":"The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate","volume":"52","author":"Lee BB","year":"2014","unstructured":"Lee BB, Cripps RA, Fitzharris M, et\u00a0al. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord. 2014;52:110\u2013116.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sc.2012.165","article-title":"Global maps of non-traumatic spinal cord injury epidemiology: towards a living data repository","volume":"52","author":"New PW","year":"2014","unstructured":"New PW, Cripps RA, Bonne Lee B. Global maps of non-traumatic spinal cord injury epidemiology: towards a living data repository. Spinal Cord. 2014;52:97\u2013109.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/204577211X13207446293695","article-title":"International standards for neurological classification of spinal cord injury","volume":"34","author":"Kirshblum SC","year":"2011","unstructured":"Kirshblum SC, Burns SP, Biering-Sorensen F, et\u00a0al. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2011;34:535\u2013546.","journal-title":"J Spinal Cord Med"},{"key":"e_1_3_3_5_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5312\/wjo.v6.i1.24","article-title":"Chronic complications of spinal cord injury","volume":"6","author":"Sezer N","year":"2015","unstructured":"Sezer N. Chronic complications of spinal cord injury. Wjo. 2015;6:24.","journal-title":"Wjo"},{"key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.sc.3101967","article-title":"Health behaviour of persons with spinal cord injury","volume":"45","author":"Bloemen-Vrencken JHA","year":"2007","unstructured":"Bloemen-Vrencken JHA, de Witte LP, Post MWM, et\u00a0al. Health behaviour of persons with spinal cord injury. Spinal Cord. 2007;45:243\u2013249.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_7_1","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin CE","year":"2013","unstructured":"Griffin CE, 3rd, Kaye AM, Bueno FR, et\u00a0al. Benzodiazepine pharmacology and central nervous system-mediated effects. The Ochsner J. 2013;13:214\u2013223.","journal-title":"The Ochsner J"},{"key":"e_1_3_3_8_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan H","year":"2012","unstructured":"Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6:11\u201316.","journal-title":"Br J Pain"},{"key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5435\/00124635-200407000-00003","article-title":"Analgesic pharmacology: II. Specific analgesics","volume":"12","author":"Phillips WJ","year":"2004","unstructured":"Phillips WJ, Currier BL. Analgesic pharmacology: II. Specific analgesics. J Am Acad Orthop Surg. 2004;12:221\u2013233.","journal-title":"J Am Acad Orthop Surg"},{"key":"e_1_3_3_10_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1179\/2045772314Y.0000000235","article-title":"The risks of polypharmacy following spinal cord injury","volume":"40","author":"Kitzman P","year":"2017","unstructured":"Kitzman P, Cecil D, Kolpek JH. The risks of polypharmacy following spinal cord injury. J Spinal Cord Med. 2017;40:147\u2013153.","journal-title":"J Spinal Cord Med"},{"key":"e_1_3_3_11_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon N","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, et\u00a0al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.","journal-title":"BMC Geriatr"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2125.2005.02543.x","article-title":"Polypharmacy and falls in the middle age and elderly population","volume":"61","author":"Ziere G","year":"2006","unstructured":"Ziere G, Dieleman JP, Hofman A, et\u00a0al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61:218\u2013223.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic D","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, et\u00a0al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989\u2013995.","journal-title":"J Clin Epidemiol"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2125.2009.03419.x","article-title":"Medication errors in elderly people: contributing factors and future perspectives","volume":"67","author":"Fialova D","year":"2009","unstructured":"Fialova D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol. 2009;67:641\u2013645.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","article-title":"Medication non-adherence among elderly patients newly discharged and receiving polypharmacy","volume":"31","author":"Pasina L","year":"2014","unstructured":"Pasina L, Brucato AL, Falcone C, et\u00a0al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31:283\u2013289.","journal-title":"Drugs Aging"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0735-6757(96)90147-3","article-title":"Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population","volume":"14","author":"Goldberg RM","year":"1996","unstructured":"Goldberg RM, Mabee J, Fau-Chan L, et\u00a0al. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14:447\u2013450.","journal-title":"Am J Emerg Med"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.5535\/arm.2017.41.4.621","article-title":"Effect of patient education on reducing medication in spinal cord injury patients with neuropathic pain","volume":"41","author":"Shin JC","year":"2017","unstructured":"Shin JC, Kim NY, Chang SH, et\u00a0al. Effect of patient education on reducing medication in spinal cord injury patients with neuropathic pain. Ann Rehabil Med. 2017;41:621\u2013630.","journal-title":"Ann Rehabil Med"},{"key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0971-6580.94506","article-title":"A survey on polypharmacy and use of inappropriate medications","volume":"19","author":"Rambhade S","year":"2012","unstructured":"Rambhade S, Chakarborty A, Shrivastava A, et\u00a0al. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012;19:68\u201373.","journal-title":"Toxicol Int"},{"key":"e_1_3_3_19_1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41393-018-0174-z","article-title":"Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada","volume":"56","author":"Guilcher SJT","year":"2018","unstructured":"Guilcher SJT, Hogan M-E, Calzavara A, et\u00a0al. Prescription drug claims following a traumatic spinal cord injury for older adults: a retrospective population-based study in Ontario, Canada. Spinal Cord. 2018;56:1059\u20131068.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_20_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sc.2015.62","article-title":"Medication profile and polypharmacy in adults with pediatric-onset spinal cord injury","volume":"53","author":"Hwang M","year":"2015","unstructured":"Hwang M, Zebracki K, Vogel LC. Medication profile and polypharmacy in adults with pediatric-onset spinal cord injury. Spinal Cord. 2015;53:673\u2013678.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_21_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1179\/2045772315Y.0000000055","article-title":"Medication-related problems in individuals with spinal cord injury in a primary care-based clinic","volume":"40","author":"Patel T","year":"2017","unstructured":"Patel T, Milligan J, Lee J. Medication-related problems in individuals with spinal cord injury in a primary care-based clinic. J Spinal Cord Med. 2017;40:54\u201361.","journal-title":"J Spinal Cord Med"},{"key":"e_1_3_3_22_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet L","year":"2007","unstructured":"Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185\u2013191.","journal-title":"Lancet"},{"key":"e_1_3_3_23_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey H","year":"2005","unstructured":"Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19\u201332.","journal-title":"Int J Soc Res Methodol"},{"key":"e_1_3_3_24_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"Levac D","year":"2010","unstructured":"Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.","journal-title":"Implement Sci"},{"key":"e_1_3_3_25_1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"Prisma extension for scoping reviews (prisma-scr): Checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et\u00a0al. Prisma extension for scoping reviews (prisma-scr): Checklist and explanation. Ann Intern Med. 2018;169:467\u2013473.","journal-title":"Ann Intern Med"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1179\/2045772311Y.0000000053","article-title":"What to call spinal cord damage not due to trauma? Implications for literature searching","volume":"35","author":"New PW","year":"2012","unstructured":"New PW, Delafosse V. What to call spinal cord damage not due to trauma? Implications for literature searching. J Spinal Cord Med. 2012;35:89\u201395.","journal-title":"J Spinal Cord Med"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer WM","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, et\u00a0al. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104:240\u2013243.","journal-title":"J Med Libr Assoc"},{"key":"e_1_3_3_28_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jrsm.1123","article-title":"A scoping review of scoping reviews: advancing the approach and enhancing the consistency","volume":"5","author":"Pham MT","year":"2014","unstructured":"Pham MT, Rajic A, Greig JD, et\u00a0al. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Syn Meth. 2014;5:371\u2013385.","journal-title":"Res Syn Meth"},{"key":"e_1_3_3_29_1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.apmr.2017.12.036","article-title":"Evaluating the use of medicare part D in the veteran population with spinal cord injury\/disorder","volume":"99","author":"Hatch MN","year":"2018","unstructured":"Hatch MN, Raad J, Suda K, et\u00a0al. Evaluating the use of medicare part D in the veteran population with spinal cord injury\/disorder. Arch Phys Med Rehabil. 2018; 99:1099\u20131107.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sc.2014.20","article-title":"Medication before and after a spinal cord lesion","volume":"52","author":"Jensen EK","year":"2014","unstructured":"Jensen EK, Biering-Sorensen F. Medication before and after a spinal cord lesion. Spinal Cord. 2014;52:358\u2013363.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_31_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.sc.3100535","article-title":"Medication usage in a spinal cord injured population","volume":"36","author":"Hope ME","year":"1998","unstructured":"Hope ME, Kailis SG, Moraes C. Medication usage in a spinal cord injured population. Spinal Cord. 1998;36:161\u2013165.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41393-017-0050-2","article-title":"Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury","volume":"56","author":"Hand BN","year":"2018","unstructured":"Hand BN, Krause JS, Simpson KN. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018;56:591\u2013597.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/16501970410020455","article-title":"Use of analgesic drugs in individuals with spinal cord injury","volume":"37","author":"Budh CN","year":"2005","unstructured":"Budh CN, Lundeberg T. Use of analgesic drugs in individuals with spinal cord injury. J Rehabil Med. 2005;37:87\u201394.","journal-title":"J Rehabil Med"},{"key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.sc.3101689","article-title":"Carbamazepine toxicity following oxybutynin and dantrolene administration: a case report","volume":"43","author":"Vander T","year":"2005","unstructured":"Vander T, Odi H, Bluvstein V, et\u00a0al. Carbamazepine toxicity following oxybutynin and dantrolene administration: a case report. Spinal Cord. 2005;43:252\u2013255.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/109662102320135379","article-title":"Refractory neuropathic pain from chronic cord compression","volume":"5","author":"Naco GJ","year":"2002","unstructured":"Naco GJ, von GC. Refractory neuropathic pain from chronic cord compression. J Pallia Med. 2002;5:433\u2013436.","journal-title":"J Pallia Med"},{"key":"e_1_3_3_36_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.apmr.2008.07.012","article-title":"Behavioral risk factors of mortality after spinal cord injury","volume":"90","author":"Krause JS","year":"2009","unstructured":"Krause JS, Carter RE, Pickelsimer E. Behavioral risk factors of mortality after spinal cord injury. Arch Phys Med Rehabil. 2009;90:95\u2013101.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_37_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.sc.3100417","article-title":"Constipation-related symptoms and bowel program concerning individuals with spinal cord injury [Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.]","volume":"35","author":"Harari D","year":"1997","unstructured":"Harari D, Sarkarati M, Gurwitz JH, et\u00a0al. Constipation-related symptoms and bowel program concerning individuals with spinal cord injury [Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.]. Spinal Cord. 1997;35:394\u2013401.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12968\/jowc.2014.23.4.165","article-title":"Factors in rehospitalisation for severe pressure ulcer care in spinal cord injury\/disorders","volume":"23","author":"Goodman BL","year":"2014","unstructured":"Goodman BL, Schindler A, Washington M, et\u00a0al. Factors in rehospitalisation for severe pressure ulcer care in spinal cord injury\/disorders. J Wound Care. 2014;23:165\u2013175.","journal-title":"J Wound Care"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sc.2017.95","article-title":"Use of medicines, adherence and attitudes to medicines among persons with chronic spinal cord injury","volume":"56","author":"H\u00f8gholen H","year":"2018","unstructured":"H\u00f8gholen H, Storhaug A, Kvernr\u00f8d K, et\u00a0al. Use of medicines, adherence and attitudes to medicines among persons with chronic spinal cord injury. Spinal Cord. 2018;56:35\u201340.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_40_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhin.2017.06.019","article-title":"Use of antibiotics and the prevalence of antibiotic-associated diarrhoea in patients with spinal cord injuries: an international, multi-centre study","volume":"97","author":"Wong S","year":"2017","unstructured":"Wong S, Santullo P, Hirani SP, et\u00a0al. Use of antibiotics and the prevalence of antibiotic-associated diarrhoea in patients with spinal cord injuries: an international, multi-centre study. J Hosp Infect. 2017;97:146\u2013152.","journal-title":"J Hosp Infect"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sc.2016.193","article-title":"Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience","volume":"55","author":"Wong S","year":"2017","unstructured":"Wong S, Santullo P, O'Driscoll J, et\u00a0al. Use of antibiotic and prevalence of antibiotic-associated diarrhoea in-patients with spinal cord injuries: a UK national spinal injury centre experience. Spinal Cord. 2017;55:583\u2013587.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1682\/JRRD.2014.08.0194","article-title":"Tapering opioid prescriptions and reducing polypharmacy for inpatients with spinal cord injury at rancho los amigos national rehabilitation center","volume":"51","author":"Atkins AM","year":"2014","unstructured":"Atkins AM, Gonzalez F, Joyo B, et\u00a0al. Tapering opioid prescriptions and reducing polypharmacy for inpatients with spinal cord injury at rancho los amigos national rehabilitation center. J Rehabil Res Dev. 2014;51:vii\u2013xiii.","journal-title":"J Rehabil Res Dev"},{"key":"e_1_3_3_43_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1179\/2045772315Y.0000000055","article-title":"Medication-related problems among patients with spinal cord injury at a primary care-based interdisciplinary clinic","volume":"40","author":"Patel T","year":"2017","unstructured":"Patel T, Milligan J, Lee FJ. Medication-related problems among patients with spinal cord injury at a primary care-based interdisciplinary clinic. J Spinal Cord Med. 2017; 40:54\u201361.","journal-title":"J Spinal Cord Med"},{"key":"e_1_3_3_44_1","unstructured":"World Health Organization. Spinal cord injury: World Health Organization; 2013 [cited 2018 Nov 21]. Available from: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/spinal-cord-injury"},{"key":"e_1_3_3_45_1","unstructured":"Duerden M Avery T Payne R. Polypharmacy and medicines optimisation: making it safe and sound. In: Brown A editor. London: The King's Fund; 2013. p. 1-68."},{"key":"e_1_3_3_46_1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/fampra\/cmy022","article-title":"Understanding medical overuse: the case of problematic polypharmacy and the potential of ethnography","volume":"35","author":"Armstrong N","year":"2018","unstructured":"Armstrong N, Swinglehurst D. Understanding medical overuse: the case of problematic polypharmacy and the potential of ethnography. Fam Pract. 2018;35:526\u2013527.","journal-title":"Fam Pract"},{"key":"e_1_3_3_47_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in Older Adults","volume":"35","author":"Salive ME","year":"2013","unstructured":"Salive ME. Multimorbidity in Older Adults. Epidemiol Rev. 2013;35:75\u201383.","journal-title":"Epidemiol Rev"},{"key":"e_1_3_3_48_1","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1056\/NEJMsb042458","article-title":"Potential pitfalls of disease-specific guidelines for patients with multiple conditions","volume":"351","author":"Tinetti ME","year":"2004","unstructured":"Tinetti ME, Bogardus ST, Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870\u20132874.","journal-title":"N Engl J Med"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1532-5415.2012.04187.x","article-title":"Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity","volume":"60","author":"American Geriatrics Society Expert Panel on the Care of Older Adults with M","year":"2012","unstructured":"American Geriatrics Society Expert Panel on the Care of Older Adults with M. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012;60:1957\u20131968.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_3_50_1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd CM","year":"2005","unstructured":"Boyd CM, Darer J, Boult C, et\u00a0al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716\u2013724.","journal-title":"JAMA"},{"key":"e_1_3_3_51_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0003-9993(99)90162-4","article-title":"Nontraumatic spinal cord injury: incidence, epidemiology, and functional outcome","volume":"80","author":"McKinley WO","year":"1999","unstructured":"McKinley WO, Seel RT, Hardman JT. Nontraumatic spinal cord injury: incidence, epidemiology, and functional outcome. Arch Phys Med Rehabil. 1999;80:619\u2013623.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_52_1","first-page":"1266","article-title":"An Italian survey of traumatic spinal cord injury. The Gruppo Italiano studio epidemiologico Mielolesioni study","volume":"84","author":"Pagliacci MC","year":"2003","unstructured":"Pagliacci MC, Celani MG, Zampolini M, et\u00a0al. An Italian survey of traumatic spinal cord injury. The Gruppo Italiano studio epidemiologico Mielolesioni study. Arch Phys Med Rehabil. 2003;84:1266\u20131275.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_53_1","first-page":"250","article-title":"Functional outcomes and disability after nontraumatic spinal cord injury rehabilitation: results from a retrospective study 1, 2","volume":"86","author":"New PW","year":"2005","unstructured":"New PW. Functional outcomes and disability after nontraumatic spinal cord injury rehabilitation: results from a retrospective study 1, 2. Arch Phys Med Rehabil. 2005;86:250\u2013261.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_54_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sc.2008.123","article-title":"Non-traumatic spinal cord lesions: epidemiology, complications, neurological and functional outcome of rehabilitation","volume":"47","author":"Gupta A","year":"2009","unstructured":"Gupta A, Taly A, Srivastava A, et\u00a0al. Non-traumatic spinal cord lesions: epidemiology, complications, neurological and functional outcome of rehabilitation. Spinal Cord. 2009;47:307\u2013311.","journal-title":"Spinal Cord"},{"key":"e_1_3_3_55_1","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.apmr.2016.12.011","article-title":"Complications of spinal cord injury over the first year after discharge from inpatient rehabilitation","volume":"98","author":"Stillman MD","year":"2017","unstructured":"Stillman MD, Barber J, Burns S, et\u00a0al. Complications of spinal cord injury over the first year after discharge from inpatient rehabilitation. Arch Phys Med Rehabil. 2017;98:1800\u20131805.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_3_56_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjopharm.2010.03.005","article-title":"Potentially inappropriate medication use in elderly Japanese patients","volume":"8","author":"Akazawa M","year":"2010","unstructured":"Akazawa M, Imai H, Igarashi A, et\u00a0al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010;8:146\u2013160.","journal-title":"Am J Geriatr Pharmacother"},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healthpol.2012.09.005","article-title":"The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009","volume":"109","author":"Hovstadius B","year":"2013","unstructured":"Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009. Health Policy. 2013;109:166\u2013174.","journal-title":"Health Policy"},{"key":"e_1_3_3_58_1","doi-asserted-by":"crossref","first-page":"e112133","DOI":"10.1371\/journal.pone.0112133","article-title":"Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study","volume":"9","author":"Ahmed B","year":"2014","unstructured":"Ahmed B, Nanji K, Mujeeb R, et\u00a0al. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014;9:e112133.","journal-title":"PLoS One"},{"key":"e_1_3_3_59_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000119460","article-title":"Association of suboptimal prescribing and change in lower extremity physical function over time","volume":"53","author":"Pugh MJ","year":"2007","unstructured":"Pugh MJ, Palmer RF, Parchman ML, et\u00a0al. Association of suboptimal prescribing and change in lower extremity physical function over time. Gerontology. 2007;53:445\u2013453.","journal-title":"Gerontology"},{"key":"e_1_3_3_60_1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/pds.2116","article-title":"Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population","volume":"20","author":"Jyrkka J","year":"2011","unstructured":"Jyrkka J, Enlund H, Lavikainen P, et\u00a0al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidem Drug Safe. 2011;20:514\u2013522.","journal-title":"Pharmacoepidem Drug Safe"},{"key":"e_1_3_3_61_1","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/ggi.12862","article-title":"Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community","volume":"17","author":"Niikawa H","year":"2017","unstructured":"Niikawa H, Okamura T, Ito K, et\u00a0al. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community. Geriatr Gerontol Int. 2017;17:1286\u20131293.","journal-title":"Geriatr Gerontol Int"},{"key":"e_1_3_3_62_1","doi-asserted-by":"crossref","first-page":"e016358","DOI":"10.1136\/bmjopen-2017-016358","article-title":"Association between polypharmacy and falls in older adults: a longitudinal study from England","volume":"7","author":"Dhalwani NN","year":"2017","unstructured":"Dhalwani NN, Fahami R, Sathanapally H, et\u00a0al. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017;7:e016358.","journal-title":"BMJ Open"},{"key":"e_1_3_3_63_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/00325481.2014.996112","article-title":"Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk","volume":"127","author":"Zia A","year":"2015","unstructured":"Zia A, Kamaruzzaman SB, Tan MP. Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk. Postgrad Med. 2015;127:330\u2013337.","journal-title":"Postgrad Med"},{"key":"e_1_3_3_64_1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/CIA.S2468","article-title":"Polypharmacy: misleading, but manageable","volume":"3","author":"Bushardt RL","year":"2008","unstructured":"Bushardt RL, Massey EB, Simpson TW, et\u00a0al. Polypharmacy: misleading, but manageable. Cia. 2008;3:383\u2013389.","journal-title":"Cia"},{"key":"e_1_3_3_65_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1517\/14740338.6.6.695","article-title":"Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable","volume":"6","author":"Salazar JA","year":"2007","unstructured":"Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf. 2007;6:695\u2013704.","journal-title":"Expert Opin Drug Saf"},{"key":"e_1_3_3_66_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jamda.2017.07.008","article-title":"Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in albacete study","volume":"19","author":"Bonaga B","year":"2018","unstructured":"Bonaga B, S\u00e1nchez-Jurado PM, Mart\u00ednez-Reig M, et\u00a0al. Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in albacete study. J Am Med Dir Assoc. 2018;19:46\u201352.","journal-title":"J Am Med Dir Assoc"},{"key":"e_1_3_3_67_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher RL","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57\u201365.","journal-title":"Expert Opin Drug Saf"},{"key":"e_1_3_3_68_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar ER","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345\u2013351.","journal-title":"Am J Geriatr Pharmacother"},{"key":"e_1_3_3_69_1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/jgs.12418","article-title":"People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe","volume":"61","author":"Reeve E","year":"2013","unstructured":"Reeve E, Wiese MD, Hendrix I, et\u00a0al. People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61:1508\u20131514.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_3_70_1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11096-015-0147-7","article-title":"Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia","volume":"37","author":"Qi K","year":"2015","unstructured":"Qi K, Reeve E, Hilmer SN, et\u00a0al. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm. 2015;37:949\u2013957.","journal-title":"Int J Clin Pharm"},{"key":"e_1_3_3_71_1","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.3399\/bjgp17X691073","article-title":"Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care","volume":"67","author":"Clyne B","year":"2017","unstructured":"Clyne B, Cooper JA, Boland F, et\u00a0al. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract. 2017;67:e507\u2013e518.","journal-title":"Br J Gen Pract"},{"key":"e_1_3_3_72_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pec.2008.08.019","article-title":"\u201cI don't know how many of these [medicines] are necessary.\u201d - a focus group study among elderly users of multiple medicines","volume":"74","author":"Moen J","year":"2009","unstructured":"Moen J, Bohm A, Tillenius T, et\u00a0al. \u201cI don't know how many of these [medicines] are necessary.\u201d - a focus group study among elderly users of multiple medicines. Patient Educ Couns. 2009;74:135\u2013141.","journal-title":"Patient Educ Couns"},{"key":"e_1_3_3_73_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40271-014-0099-3","article-title":"Understanding patient preferences in medication nonadherence: a review of stated preference data","volume":"8","author":"Laba T-L","year":"2015","unstructured":"Laba T-L, Essue B, Kimman M, et\u00a0al. Understanding patient preferences in medication nonadherence: a review of stated preference data. Patient. 2015;8:385\u2013395.","journal-title":"Patient"},{"key":"e_1_3_3_74_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1310\/sci1903-195","article-title":"Rehabilitation of patients with nontraumatic spinal cord injury in the Netherlands: etiology, length of stay, and functional outcome","volume":"19","author":"Vervoordeldonk JJ","year":"2013","unstructured":"Vervoordeldonk JJ, Post MWM, New P, et\u00a0al. Rehabilitation of patients with nontraumatic spinal cord injury in the Netherlands: etiology, length of stay, and functional outcome. Top Spinal Cord Inj Rehabil. 2013;19:195\u2013201.","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"e_1_3_3_75_1","doi-asserted-by":"crossref","first-page":"W253","DOI":"10.1377\/hlthaff.W2.253","article-title":"Prescription drug coverage and seniors: how well are states closing the gap?","volume":"21","author":"Safran DG","year":"2002","unstructured":"Safran DG, Neuman P, Schoen C, et\u00a0al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;21:W253\u2013W268.","journal-title":"Health Aff (Millwood)"},{"key":"e_1_3_3_76_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.socscimed.2017.10.007","article-title":"Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application","volume":"194","author":"Goldsmith LJ","year":"2017","unstructured":"Goldsmith LJ, Kolhatkar A, Popowich D, et\u00a0al. Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application. Soc Sci Med. 2017;194:51\u201359.","journal-title":"Soc Sci Med"},{"key":"e_1_3_3_77_1","first-page":"3","article-title":"Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease","volume":"27","author":"Hennessy D","year":"2016","unstructured":"Hennessy D, Sanmartin C, Ronksley P, et\u00a0al. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. Health Rep. 2016;27:3\u20138.","journal-title":"Health Rep"},{"key":"e_1_3_3_78_1","first-page":"13","article-title":"Trends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009","volume":"25","author":"Sanmartin C","year":"2014","unstructured":"Sanmartin C, Hennessy D, Lu Y, et\u00a0al. Trends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009. Health Rep. 2014;25:13\u201317.","journal-title":"Health Rep"},{"key":"e_1_3_3_79_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1258\/jhsrp.2009.009059","article-title":"Determinants of self-reported medicine underuse due to cost: a comparison of seven countries","volume":"15","author":"Kemp A","year":"2010","unstructured":"Kemp A, Roughead E, Preen D, et\u00a0al. Determinants of self-reported medicine underuse due to cost: a comparison of seven countries. J Health Serv Res Policy. 2010;15:106\u2013114.","journal-title":"J Health Serv Res Policy"},{"key":"e_1_3_3_80_1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.clinthera.2006.07.009","article-title":"A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health","volume":"28","author":"Kennedy J","year":"2006","unstructured":"Kennedy J, Morgan S. A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health. Clin Ther. 2006;28:1217\u20131224.","journal-title":"Clin Ther"},{"key":"e_1_3_3_81_1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2147\/PPA.S170417","article-title":"Cost-related nonadherence to prescription medications in Canada: a scoping review","volume":"12","author":"Gupta S","year":"2018","unstructured":"Gupta S, McColl MA, Guilcher SJ, et\u00a0al. Cost-related nonadherence to prescription medications in Canada: a scoping review. Ppa. 2018;12:1699\u20131715.","journal-title":"Ppa"}],"container-title":["Disability and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09638288.2019.1610085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:45:17Z","timestamp":1695465917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09638288.2019.1610085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":80,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2020,12,17]]}},"alternative-id":["10.1080\/09638288.2019.1610085"],"URL":"https:\/\/doi.org\/10.1080\/09638288.2019.1610085","relation":{},"ISSN":["0963-8288","1464-5165"],"issn-type":[{"value":"0963-8288","type":"print"},{"value":"1464-5165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idre20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idre20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}